Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results

KWALITY PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 20.797.03-63.65475.4870.50

What is the latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS is 20.79 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202520.79
Mar20247.03
Mar2023-63.65
Mar2022475.48
Mar202170.50

How is Core EBITDA Growth of KWALITY PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 20.79
195.73
Mar2024 7.03
Positive
Mar2023 -63.65
Negative
Mar2022 475.48
574.44
Mar2021 70.5 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹1,009.9 Cr -1.2% -4.1% 21.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,368.0 Cr 0.7% -0.7% -11% Stock Analytics
DIVIS LABORATORIES ₹160,631.0 Cr NA -1.6% 12.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,641.0 Cr 3.1% -0.9% 9.1% Stock Analytics
CIPLA ₹123,419.0 Cr -2% -4% -5.9% Stock Analytics
DR REDDYS LABORATORIES ₹109,176.0 Cr -0.2% 2.4% 0% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

-1.2%

-4.1%

21.7%

SENSEX

-0.3%

0.1%

-1%


You may also like the below Video Courses